The blood brain barrier (BBB) is a tried and true
protection for the brain from all sorts of chemicals and other molecules that
are in the blood. Brain capillaries
shelter the brain by forming a highly selective permeable layer that limit
transport via membrane carriers and channels(2). The lipophilic membrane keeps water soluble
molecules without membrane carriers or channels from crossing the barrier and
into the brain. Early anti-histamines
were lipid soluble and freely and easily crossed the BBB causing unwanted drowsiness
in patients taking these drugs. By
changing the structures of these anti-histamines, making them less
lipid-soluble, non-drowsy allergy medicines were developed(2).
Neurobiologists from Genentech in South San
Francisco have developed an antibody capable of crossing the BBB and help limit
the damage done by Alzheimer’s disease (AD).
The damage to neural function due to AD is caused by the aggregation of
protein amyloid-β(1). Amyloid-β is created by an enzyme
called β-secretase 1 (BACE1). The
antibody developed by Genentech binds to an iron transporter called transferrin
that typically carries iron across the BBB.
The antibody binds to transferrin, is transported across the BBB and
then binds, with a higher affinity, to BACE1, blocking amyloid- β
production(1). Recent studies have shown
decreases in plasma levels of amyloid- β up to as much as fifty-percent
in mouse and monkey models.
As technology progresses, so will
the treatment of pathologies that we previously viewed as death sentences. As future health care workers, we will be
using techniques and ideas that we now only have limited understanding of. I am very excited to see where medicine will
go, but at the same time I have to worry if the technology may ultimately pass
me by. In this career path, we will
always be learning and will always be working to provide the best and most
successful treatment options for our patients.
Silverthorn DU. 2010. Human Physiology: An
Integrated Approach. 5th ed. California: Pearson Education, INC.
303-305 p.
Reardon S. 2014. Alzheimer's
drug sneaks through blood–brain barrier. Nature Publishing Group. Available
from: http://www.nature.com/news/alzheimer-s-drug-sneaks-through-blood-brain-barrier-1.16291
No comments:
Post a Comment